FibroGen (Mexico) Buy Hold or Sell Recommendation
| FGEN Stock | MXN 7.94 0.89 12.62% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding FibroGen is 'Strong Sell'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell FibroGen given historical horizon and risk tolerance towards FibroGen. When Macroaxis issues a 'buy' or 'sell' recommendation for FibroGen, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out FibroGen Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For more information on how to buy FibroGen Stock please use our How to Invest in FibroGen guide. In addition, we conduct extensive research on individual companies such as FibroGen and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards FibroGen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
FibroGen |
Execute FibroGen Buy or Sell Advice
The FibroGen recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on FibroGen. Macroaxis does not own or have any residual interests in FibroGen or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute FibroGen's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Relatively risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Quite High | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
FibroGen Trading Alerts and Improvement Suggestions
| FibroGen had very high historical volatility over the last 90 days | |
| FibroGen has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 235.31 M. Net Loss for the year was (290.02 M) with loss before overhead, payroll, taxes, and interest of (104.61 M). | |
| FibroGen has accumulated about 565.4 M in cash with (82.23 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.56. | |
| Over 79.0% of the company shares are owned by institutional investors |
FibroGen Returns Distribution Density
The distribution of FibroGen's historical returns is an attempt to chart the uncertainty of FibroGen's future price movements. The chart of the probability distribution of FibroGen daily returns describes the distribution of returns around its average expected value. We use FibroGen price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of FibroGen returns is essential to provide solid investment advice for FibroGen.
| Mean Return | 0.36 | Value At Risk | -8.54 | Potential Upside | 12.62 | Standard Deviation | 5.46 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of FibroGen historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
FibroGen Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to FibroGen or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that FibroGen's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a FibroGen stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.36 | |
β | Beta against Dow Jones | -0.13 | |
σ | Overall volatility | 5.29 | |
Ir | Information ratio | 0.04 |
FibroGen Volatility Alert
FibroGen is showing large volatility of returns over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure FibroGen's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact FibroGen's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.FibroGen Fundamentals Vs Peers
Comparing FibroGen's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze FibroGen's direct or indirect competition across all of the common fundamentals between FibroGen and the related equities. This way, we can detect undervalued stocks with similar characteristics as FibroGen or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of FibroGen's fundamental indicators could also be used in its relative valuation, which is a method of valuing FibroGen by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare FibroGen to competition |
| Fundamentals | FibroGen | Peer Average |
| Return On Equity | -1.85 | -0.31 |
| Return On Asset | -0.27 | -0.14 |
| Profit Margin | (2.94) % | (1.27) % |
| Operating Margin | (2.52) % | (5.51) % |
| Current Valuation | 21.87 B | 16.62 B |
| Shares Outstanding | 93.96 M | 571.82 M |
| Shares Owned By Insiders | 7.82 % | 10.09 % |
| Shares Owned By Institutions | 78.80 % | 39.21 % |
| Price To Book | 54.45 X | 9.51 X |
| Price To Sales | 231.63 X | 11.42 X |
| Revenue | 235.31 M | 9.43 B |
| Gross Profit | (104.61 M) | 27.38 B |
| EBITDA | (288.53 M) | 3.9 B |
| Net Income | (290.02 M) | 570.98 M |
| Cash And Equivalents | 565.4 M | 2.7 B |
| Cash Per Share | 6.56 X | 5.01 X |
| Total Debt | 77.14 M | 5.32 B |
| Debt To Equity | 15.10 % | 48.70 % |
| Current Ratio | 6.16 X | 2.16 X |
| Book Value Per Share | 0.28 X | 1.93 K |
| Cash Flow From Operations | (82.23 M) | 971.22 M |
| Earnings Per Share | (62.14) X | 3.12 X |
| Number Of Employees | 566 | 18.84 K |
| Beta | 0.85 | -0.15 |
| Market Capitalization | 43.36 B | 19.03 B |
| Total Asset | 773.82 M | 29.47 B |
| Net Asset | 773.82 M |
FibroGen Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as FibroGen . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About FibroGen Buy or Sell Advice
When is the right time to buy or sell FibroGen? Buying financial instruments such as FibroGen Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having FibroGen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sector ETFs Thematic Idea Now
Sector ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sector ETFs theme has 440 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sector ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for FibroGen Stock Analysis
When running FibroGen's price analysis, check to measure FibroGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroGen is operating at the current time. Most of FibroGen's value examination focuses on studying past and present price action to predict the probability of FibroGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroGen's price. Additionally, you may evaluate how the addition of FibroGen to your portfolios can decrease your overall portfolio volatility.